Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
AstraZeneca
UBS
Dow
Moodys
Argus Health
Julphar
Accenture
Boehringer Ingelheim

Generated: May 20, 2018

DrugPatentWatch Database Preview

OXYTETRACYCLINE HYDROCHLORIDE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Oxytetracycline Hydrochloride patents expire, and what generic alternatives are available?

Oxytetracycline Hydrochloride is a drug marketed by Hikma Pharms, Impax Labs, Proter, and Purepac Pharm. and is included in four NDAs.

The generic ingredient in OXYTETRACYCLINE HYDROCHLORIDE is oxytetracycline hydrochloride. There are thirty-six drug master file entries for this compound. Additional details are available on the oxytetracycline hydrochloride profile page.
Summary for OXYTETRACYCLINE HYDROCHLORIDE
Drug patent expirations by year for OXYTETRACYCLINE HYDROCHLORIDE

US Patents and Regulatory Information for OXYTETRACYCLINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Pharms OXYTETRACYCLINE HYDROCHLORIDE oxytetracycline hydrochloride CAPSULE;ORAL 060770-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Purepac Pharm OXYTETRACYCLINE HYDROCHLORIDE oxytetracycline hydrochloride CAPSULE;ORAL 060634-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Impax Labs OXYTETRACYCLINE HYDROCHLORIDE oxytetracycline hydrochloride CAPSULE;ORAL 060760-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Proter OXYTETRACYCLINE HYDROCHLORIDE oxytetracycline hydrochloride CAPSULE;ORAL 060869-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Federal Trade Commission
Cantor Fitzgerald
Deloitte
Medtronic
Julphar
Cipla
Baxter
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.